1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. REPLIGEN CORP.
161.69 -0.34 (-0.21%)
741.5K
XNAS Volume

XNAS 15 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert

Repligen Corp - RGEN - stock price prediction, stock price target, analyst ratings from 21 analysts

Repligen Corp has a share price target of US$ 190, revenue growth forecast of 15.6%, and profit growth estimate of 287.2% for FY25, based on top 21 analyst calls.